You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL1

Showing 51 - 75 of 745
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Immune Checkpoint Inhibitors (AUTENTIC)

Recruiting
  • Cancer
  • +2 more
  • Treatment with immune checkpoint inhibitors.
  • Blood tests.
  • Vitoria, Álava, Spain
    Hospital Universitario Araba
Aug 27, 2021

Tumor, Esophagus, Malignant Esophagus Tumor, Tumor, Esophageal Trial in Amsterdam (Bintrafusp alfa)

Recruiting
  • Neoplasm, Esophagus
  • +2 more
  • Bintrafusp alfa
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Jan 15, 2021

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

Unknown status
  • Bullous Pemphigoid
  • +2 more
  • Not concerned
  • Nantes, France
    University Hospital
Nov 18, 2020

Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in France (Selicrelumab, Atezolizumab)

Terminated
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Créteil, France
  • +4 more
Jul 23, 2021

Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

Recruiting
  • Melanoma (Skin)
  • Non-Small-Cell Lung Carcinoma
  • GAd-PEV
  • MVA-PEV
  • Charleroi, Belgium
  • +6 more
Feb 23, 2022

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

PDL1 in Ovarian High Grade Serous Carcinoma

Completed
  • Ovarian Cancer
  • immunohistochemical staining
  • Port Said, Egypt
    Faculty of Medicine, Port Said University
Aug 6, 2020

NSCLC, Progression, Disease Trial in Paris (Resting Energy Expenditure measurement)

Completed
  • Non-small Cell Lung Cancer
  • Progression, Disease
  • Resting Energy Expenditure measurement
  • Paris, France
    Cochin Hospital
May 10, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Metastatic Solid Tumors Trial in Canada, United States (M6223, Bintrafusp alfa)

Recruiting
  • Metastatic Solid Tumors
  • Nashville, Tennessee
  • +3 more
Oct 14, 2021

Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)

Completed
  • Metastatic Renal Cell Carcinoma
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Apr 23, 2021

Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage III Trial in Worldwide (Durvalumab Injection)

Recruiting
  • Cancer
  • +4 more
  • Durvalumab Injection
  • Tallinn, Estonia
  • +9 more
Dec 1, 2021

Carcinoma, Squamous Cell, Oesophageal Cancer Trial in Amsterdam (External beam radiotherapy, Bintrafusp alfa, Paclitaxel)

Recruiting
  • Carcinoma, Squamous Cell
  • Oesophageal Cancer
  • External beam radiotherapy
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Jan 15, 2021

Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Colon Adenocarcinoma
  • +10 more
  • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Primary Liver Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Primary Liver Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Apr 21, 2021

Hepatocellular Carcinoma, Thermal Ablation, Anlotinib Trial in Beijing (Anlotinib and TQB2450 solution, TQB2450 solution)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Anlotinib and TQB2450 solution
  • TQB2450 solution
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 2, 2021

Recurrent Head and Neck Squamous Cell Carcinoma, Second Primary Squamous Cell Carcinoma of the Head and Neck Trial in Houston

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Second Primary Squamous Cell Carcinoma of the Head and Neck
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Advanced Malignant Solid Tumor Trial in ShangHai (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Advanced Malignant Solid Tumor
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • ShangHai, Shanghai, China
  • +1 more
Apr 26, 2021

NSCLC, Melanoma Trial in London ([99mTc]-NM01 SPECT)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Melanoma
  • [99mTc]-NM01 SPECT
  • London, United Kingdom
    Guy's and St Thomas' NHS Foundation Trust
Jun 15, 2020

Advanced Solid Tumor, NSCLC Trial in Taiwan, United States (NM21-1480)

Recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancer
  • NM21-1480
  • Pittsburgh, Pennsylvania
  • +3 more
May 18, 2021

Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
  • Combination PD-1/PD-L1 ICI + VEGFR-TKI
  • Treatment pause
  • Bayonne, France
  • +24 more
Aug 10, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021